103 related articles for article (PubMed ID: 10974878)
1. [Precancerous states of the larynx: analysis of mono- and polyclonality of the cells with high proliferative index (p53, PCNA)].
Gabriel A; Namysłowski G; Drozdzowska B; Morawski K; Steplewska-Mazur K; Gwóźdź M
Otolaryngol Pol; 2000; 54 Suppl 31():178-81. PubMed ID: 10974878
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
3. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
[TBL] [Abstract][Full Text] [Related]
4. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx.
Fouret P; Dabit D; Sibony M; Alili D; Commo F; Saint-Guily JL; Callard P
Am J Pathol; 1995 Mar; 146(3):599-604. PubMed ID: 7887442
[TBL] [Abstract][Full Text] [Related]
8. [The meaning of the expression of PCNA and c-erbB-2 in the hyperplasia of laryngeal epithelium].
Yao Q; Lu X; Huang Z; Cao Y; Jiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 13(6):263-4. PubMed ID: 12563981
[TBL] [Abstract][Full Text] [Related]
9. Barrett's oesophagus: mucin composition, neuroendocrine cells, p53 protein, cellular proliferation and differentiation.
Jaskiewicz K; Louw J; Anichkov N
Anticancer Res; 1994; 14(5A):1907-12. PubMed ID: 7847825
[TBL] [Abstract][Full Text] [Related]
10. Expression of PCNA and p53 in esophageal dysplasia and esophageal carcinoma.
Murakami S; Uchida Y; Takeno S; Noguchi T; Matsumoto K; Shimoda H
Surg Today; 1997; 27(7):593-9. PubMed ID: 9306559
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between tumor cell proliferating activity and biological behavior, prognosis in laryngeal carcinoma].
Zhou G; Liang C; Lin D; Zhang X; Wen D; Liu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):178-81. PubMed ID: 10684010
[TBL] [Abstract][Full Text] [Related]
12. Expression of proliferating cell nuclear antigen in premalignant lesions of the larynx.
Zhao R; Hirano M; Kurita S
Am J Otolaryngol; 1996; 17(1):36-44. PubMed ID: 8801814
[TBL] [Abstract][Full Text] [Related]
13. Expression of proliferating cell nuclear antigen (PCNA) in oral submucous fibrosis, oral epithelial hyperkeratosis and oral epithelial dysplasia in Taiwan.
Chiang CP; Lang MJ; Liu BY; Wang JT; Leu JS; Hahn LJ; Kuo MY
Oral Oncol; 2000 Jul; 36(4):353-9. PubMed ID: 10899674
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
[TBL] [Abstract][Full Text] [Related]
15. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
16. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
Zhou G; Lin D; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
[TBL] [Abstract][Full Text] [Related]
17. Morphometric characteristics of cell proliferation and p53 expression in development of experimentally induced respiratory tumors.
Laitakari J; Harrison D; Stenbäck F
Anal Quant Cytol Histol; 2001 Aug; 23(4):273-86. PubMed ID: 11531142
[TBL] [Abstract][Full Text] [Related]
18. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
19. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of usefulness of PCNA and protein p53 in subjects with laryngeal cancer with local recurrence].
Morawski K; Gabriel A; Namysłowski G; Pietrawska V; Ziółkowski A; Urbaniec P
Otolaryngol Pol; 2000; 54 Suppl 31():174-7. PubMed ID: 10974877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
